These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 15347486)
1. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Navi D; Huntley A Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486 [TBL] [Abstract][Full Text] [Related]
2. Viral and nonviral uses of imiquimod: a review. Gupta AK; Cherman AM; Tyring SK J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314 [TBL] [Abstract][Full Text] [Related]
3. Imiquimod for superficial and in situ skin malignancy. Drug Ther Bull; 2009 Oct; 47(10):113-6. PubMed ID: 19809085 [TBL] [Abstract][Full Text] [Related]
4. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. Flowers F Int J Dermatol; 2002 May; 41 Suppl 1():12-5. PubMed ID: 12087813 [No Abstract] [Full Text] [Related]
5. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. Wolf IH; Kodama K; Cerroni L; Kerl H Am J Dermatopathol; 2007 Jun; 29(3):237-41. PubMed ID: 17519620 [TBL] [Abstract][Full Text] [Related]
8. Role of topical therapies in the management of cutaneous disease. Skinner R J Cutan Med Surg; 2004; 8 Suppl 3():22-31. PubMed ID: 15647859 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Rosen T; Harting M; Gibson M Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376 [TBL] [Abstract][Full Text] [Related]
10. Imiquimod - Its role in the treatment of cutaneous malignancies. Bubna AK Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulators for skin cancer. Villa AM; Berman B J Drugs Dermatol; 2004; 3(5):533-9. PubMed ID: 15552605 [TBL] [Abstract][Full Text] [Related]
12. [New perspective in immunotherapy: local imiquimod treatment]. Kemény L; Nagy N Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. van Meurs T; van Doorn R; Kirtschig G Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589 [No Abstract] [Full Text] [Related]
14. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Karrer S; Szeimies RM; Hohenleutner U; Landthaler M Am J Clin Dermatol; 2001; 2(4):229-37. PubMed ID: 11705250 [TBL] [Abstract][Full Text] [Related]
15. Imiquimod as an antiaging agent. Metcalf S; Crowson AN; Naylor M; Haque R; Cornelison R J Am Acad Dermatol; 2007 Mar; 56(3):422-5. PubMed ID: 17184874 [TBL] [Abstract][Full Text] [Related]
16. The use of imiquimod in the treatment of periocular tumours. Ross AH; Kennedy CT; Collins C; Harrad RA Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545 [TBL] [Abstract][Full Text] [Related]
17. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150 [No Abstract] [Full Text] [Related]
18. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Wagstaff AJ; Perry CM Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284 [TBL] [Abstract][Full Text] [Related]
19. [Topical chemotherapy for carcinoma of the skin (author's transl)]. Miki Y; Kawatsu T; Matsuda H; Yamada T; Kahata A Jpn J Antibiot; 1975 Feb; 28(1):37-43. PubMed ID: 47924 [No Abstract] [Full Text] [Related]